Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms.

Gray WN, Denson LA, Baldassano RN, Hommel KA.

J Pediatr Psychol. 2012 Apr;37(3):282-91. doi: 10.1093/jpepsy/jsr092. Epub 2011 Nov 10.

2.

Behavioral functioning in youth with inflammatory bowel disease: perceived barriers as mediator of medication adherence.

Reed-Knight B, Lewis JD, Blount RL.

J Pediatr Psychol. 2013 Apr;38(3):309-20. doi: 10.1093/jpepsy/jss122. Epub 2012 Dec 17.

PMID:
23248344
3.

Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.

Nahon S, Lahmek P, Saas C, Durance C, Olympie A, Lesgourgues B, Gendre JP.

Inflamm Bowel Dis. 2011 Jun;17(6):1270-6. doi: 10.1002/ibd.21482. Epub 2010 Oct 25.

PMID:
21560190
4.

Risk factors for depression in the elderly inflammatory bowel disease population.

Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS.

J Crohns Colitis. 2014 Feb;8(2):113-9. doi: 10.1016/j.crohns.2013.07.002. Epub 2013 Aug 6.

5.

Barriers to oral medication adherence for adolescents with inflammatory bowel disease.

Ingerski LM, Baldassano RN, Denson LA, Hommel KA.

J Pediatr Psychol. 2010 Jul;35(6):683-91. doi: 10.1093/jpepsy/jsp085. Epub 2009 Sep 23.

6.

Oral medication adherence and disease severity in pediatric inflammatory bowel disease.

Hommel KA, Denson LA, Baldassano RN.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):250-4. doi: 10.1097/MEG.0b013e328344019c.

7.

Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.

Walter JG, Kahn SA, Noe JD, Schurman JV, Miller SA, Greenley RN.

Inflamm Bowel Dis. 2016 Feb;22(2):402-8. doi: 10.1097/MIB.0000000000000657.

PMID:
26756694
8.

Religious coping and its influence on psychological distress, medication adherence, and quality of life in inflammatory bowel disease.

Freitas TH, Hyphantis TN, Andreoulakis E, Quevedo J, Miranda HL, Alves GS, Souza MH, Braga LL, Pargament KI, Soczynska JK, McIntyre RS, Carvalho AF.

Rev Bras Psiquiatr. 2015 Jul-Sep;37(3):219-27. doi: 10.1590/1516-4446-2014-1507.

9.

Adherence to Oral Maintenance Treatment in Adolescents With Inflammatory Bowel Disease.

Spekhorst LM, Hummel TZ, Benninga MA, van Rheenen PF, Kindermann A.

J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):264-70. doi: 10.1097/MPG.0000000000000924. Review.

PMID:
26230905
10.

Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.

Hommel KA, Baldassano RN.

J Pediatr Psychol. 2010 Oct;35(9):1005-10. doi: 10.1093/jpepsy/jsp126. Epub 2009 Dec 21.

11.

Quality of life in adolescents with inflammatory bowel disease and their parents--comparison with healthy controls.

Jelenova D, Prasko J, Ociskova M, Karaskova E, Hunkova M, Kolarova J, Vydra D, Holubova M, Hruby R, Latalova K, Mihal V.

Neuro Endocrinol Lett. 2015;36(8):787-92.

PMID:
26921580
12.

Medication adherence and quality of life in pediatric inflammatory bowel disease.

Hommel KA, Davis CM, Baldassano RN.

J Pediatr Psychol. 2008 Sep;33(8):867-74. doi: 10.1093/jpepsy/jsn022. Epub 2008 Mar 11.

13.

Barriers to adherence among adolescents with inflammatory bowel disease.

Greenley RN, Stephens M, Doughty A, Raboin T, Kugathasan S.

Inflamm Bowel Dis. 2010 Jan;16(1):36-41. doi: 10.1002/ibd.20988.

PMID:
19434722
14.

Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.

Freitas TH, Andreoulakis E, Alves GS, Miranda HL, Braga LL, Hyphantis T, Carvalho AF.

World J Gastroenterol. 2015 Jun 7;21(21):6713-27. doi: 10.3748/wjg.v21.i21.6713.

15.

Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review.

Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H.

J Psychosom Res. 2016 Aug;87:70-80. doi: 10.1016/j.jpsychores.2016.06.001. Epub 2016 Jun 6. Review.

PMID:
27411754
16.

Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.

Castaneda AE, Tuulio-Henriksson A, Aronen ET, Marttunen M, Kolho KL.

World J Gastroenterol. 2013 Mar 14;19(10):1611-7. doi: 10.3748/wjg.v19.i10.1611.

17.

Emotional functioning, barriers, and medication adherence in pediatric transplant recipients.

McCormick King ML, Mee LL, GutiƩrrez-Colina AM, Eaton CK, Lee JL, Blount RL.

J Pediatr Psychol. 2014 Apr;39(3):283-93. doi: 10.1093/jpepsy/jst074. Epub 2013 Sep 29.

PMID:
24080552
18.

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, Tillinger W, Gangl A, Moser G.

Psychosom Med. 2004 Jan-Feb;66(1):79-84.

PMID:
14747641
19.

An exploration of family problem-solving and affective involvement as moderators between disease severity and depressive symptoms in adolescents with inflammatory bowel disease.

Schuman SL, Graef DM, Janicke DM, Gray WN, Hommel KA.

J Clin Psychol Med Settings. 2013 Dec;20(4):488-96. doi: 10.1007/s10880-013-9368-x.

20.

Depressive symptoms in youth with inflammatory bowel disease compared with a community sample.

Reed-Knight B, Lobato D, Hagin S, McQuaid EL, Seifer R, Kopel SJ, Boergers J, Nassau JH, Suorsa K, Bancroft B, Shapiro J, Leleiko NS.

Inflamm Bowel Dis. 2014 Apr;20(4):614-21. doi: 10.1097/01.MIB.0000442678.62674.b7.

Supplemental Content

Support Center